<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Barret's esophagus (BE) is defined as a situation in which the distal esophageal squamous epithelium was replaced by columnar epithelium, with or without goblet cells </plain></SENT>
<SENT sid="1" pm="."><plain>BE is considered a significant risk factor for the development of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, however, screening is recommended only for high risk patients </plain></SENT>
<SENT sid="2" pm="."><plain>The new guidelines determine the proper terminology of the endoscopic appearance of BE and the way that biopsies should be taken </plain></SENT>
<SENT sid="3" pm="."><plain>After BE is confirmed, surveillance is extremely important as its performance has been shown to prevent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The surveillance is based on the endoscopic and pathological findings, highlighting the importance of advanced endoscopy and specialized pathology expertise </plain></SENT>
<SENT sid="5" pm="."><plain>The guidelines determine the place of the endoscopic ablative technology and specialized surgery in these patients </plain></SENT>
</text></document>